(19)
(11) EP 4 518 851 A2

(12)

(43) Date of publication:
12.03.2025 Bulletin 2025/11

(21) Application number: 24719451.7

(22) Date of filing: 20.02.2024
(51) International Patent Classification (IPC): 
A61K 31/352(2006.01)
A61K 36/185(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/10; A61K 9/1617; A61K 31/658
(86) International application number:
PCT/US2024/016571
(87) International publication number:
WO 2025/024008 (30.01.2025 Gazette 2025/05)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 24.07.2023 US 202318225227
24.07.2023 US 202318225234
24.07.2023 US 202318225244

(71) Applicant: Poviva Corp.
Carson City, NV 89701 (US)

(72) Inventors:
  • DOCHERTY, John
    Port Perry, Ontario L9L 1V1 (CA)
  • BUNKA, Christopher Andrew
    Kelowna, British Colombia V1P 1R7 (CA)

(74) Representative: Marks & Clerk LLP 
15 Fetter Lane
London EC4A 1BW
London EC4A 1BW (GB)

   


(54) COMPOSITIONS AND METHODS FOR TREATING EPILEPSY